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Pseudomonas aeruginosa l-arginine deiminase, an enzyme catalyzing
the irreversible catabolism of arginine to citrulline, has been
produced in selenomethionyl form. The protein was puri®ed and
crystallized by the sitting-drop vapour-diffusion method using a
precipitant solution consisting of 55% MPD, 100 mM cacodylate pH
6.5, 20 mM MgCl2. Crystals display tetragonal symmetry (P41212 or
P43212), with unit-cell parameters a = b = 106.0, c = 300.2 AÊ , and
diffract to 2.7 AÊ resolution. A complete MAD data set was collected
to 3.2 AÊ resolution on beamline BM30 at ESRF.
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1. Introduction
Pseudomonas aeruginosa (PAO), a Gram-
negative bacterium, is an opportunistic human
pathogen that causes a wide variety of infec-
tions, particularly in victims of severe burns
and in immunosuppressed patients. This makes
P. aeruginosa one of the most prevalent
pathogens in hospital-acquired infection. The
potential pathogenicity of PAO is greatly
enhanced by a remarkable nutritional versati-
lity that enables this organism to survive in
diverse and harsh environments.
The signi®cance of arginine catabolism in
this organism is re¯ected by the unusual
presence of four pathways for its utilization.
P. aeruginosa can utilize arginine aerobic
conditions as a sole source of carbon, energy
and nitrogen via the arginine succinyl-
transferase pathway (Cunin et al., 1986). PAO
also utilizes arginine as an energy source under
anaerobic conditions via the l-arginine de-
iminase (ADI; EC 3.5.3.6) pathway.
In P. aeruginosa the genetics of the arginine
deiminase pathway have been well studied.
The genes encoding the enzyme of the ADI
pathway are organized in an arcDABC operon
(Rella et al., 1985; Vander Wauven et al., 1984).
Expression of this operon is induced under
conditions of oxygen limitation (Mercenier et
al., 1980).
The arcA gene encodes the arginine de-
iminase (EC 3.5.3.6) that catalyzes the deimi-
nation of the guanidino group of l-arginine to
produce citrulline and ammonia. The catabolic
ornithine carbamoyltransferase (EC 2.1.3.3),
encoded by the arcB gene, cleaves citrulline to
ornithine and carbamoyl phosphate. The arcC
gene encodes the carbamate kinase (EC
2.7.2.2) that catalyzes the formation of ATP
from carbamoyl phosphate and ADP. The
fourth gene, arcD, encodes a membrane-bound
protein that is necessary for the uptake of
arginine and the excretion of ornithine. This
transport process is driven by a concentration
gradient (LuÈ thi et al., 1990; Verhoogt et al.,
1992).
The arginine deiminase pathway, normally
con®ned to the prokaryotic kingdom, has also
been discovered in the primitive eukaryotic
organism Giardia intestinalis and is an impor-
tant fuel in its overall energy metabolism
(Edwards et al., 1992). ADI from G. intestinalis
(580 amino acids) shares about 60% sequence
homology with the PAO enzyme (417 amino
acids), but contains an extra segment (about
120 residues) on its C-terminus.
Protozoa of the genus Giardia are ubiqui-
tous parasites that colonize the mucosa of the
gastrointestinal tracts of human and animals
(Adam, 1991). A number of different classes of
drugs have been successful in therapy for
giardiasis worldwide (Upcroft & Upcroft,
2001). Resistance to metronidazole in
G. intestinalis has been documented (Adagu et
al., 2002). Should resistance to metronidazole
or its analogue become widespread, new active
compounds will be needed.
The search for alternative antigiardials,
which relies on the intimate knowledge of
Giardia biochemistry, metabolism and
molecular biology, is essential. Consequently,
arginine deiminase could be a potential ther-
apeutic target for the treatment of Giardia
infection.
In both P. aeruginosa and Giardia,
l-arginine deiminase appears to be a key
enzyme and a drug target for potential anti-
bacterial or antigiardials design. As the ®rst
step towards structure elucidation of this
enzyme, we report here the overexpression,
crystallization and preliminary X-ray diffrac-
tion studies of P. aeruginosa ADI.
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2. Material and methods
2.1. Cloning and overexpression
The vector pET30.b (Novagen) was used
for ADI expression. The arcA gene
encoding the P. aeruginosa arginine deimi-
nase was ampli®ed by PCR using pME183 as
template (LuÈ thi et al., 1986). The forward
(50-GGCCTCGAGTCAGTAGTCGATCG-
GGTCGCGG-30) and reverse (50-GGC-
ATATGAGCACGGAAAAAACCAAAC-
TTGGCG-30) oligonucleotide primers were
designed using the published sequence
(Baur et al., 1989).
The PCR product was initially cloned into
pCR2.1 (Invitrogen); after sequence con®r-
mation, the gene was excized and subcloned
into pET30.b as an NdeI/EcoRI fragment.
The plasmid encoding arginine deiminase
was transformed into Escherichia coli strain
BL21(DE3)pLysS for protein expression.
To help structure solution, seleno-
methionyl (SeMet) ADI was produced using
the method described by DoublieÂ (1997).
Expression of the recombinant enzyme was
induced overnight at 288 K using 1 mM
isopropyl-thio--d-galactoside.
Cells from 4 l of culture were resuspended
in 20 mM Tris±HCl pH 7.4, 10% glycerol,
0.2 mM EDTA, 3 mM -mercaptoethanol.
Cell disruption was achieved by sonication.
Debris was removed by centrifugation at
12 000g for 20 min.
2.2. Purification
Recombinant SeMet-containing P. aeru-
ginosa arginine deiminase was puri®ed by a
three-step column chromatography proce-
dure: (i) a DEAE-Sepharose column equi-
librated with 10 mM Tris±HCl, 10% glycerol,
0.2 mM EDTA, 3 mM -mercaptoethanol
was eluted using a linear gradient of
0±400 mM MgCl2; (ii) an arginine Sepharose
column pre-equilibrated with the same
sample was eluted with a linear gradient of
arginine (0±200 mM); (iii) the most active
fractions (Archibald, 1944) were applied to a
column of Resource Q. Arginine deiminase
was eluted with a 0±150 mM gradient of
MgCl2.
Fractions were analyzed by SDS±PAGE
(Fig. 1) and in vitro enzyme assay (Archi-
bald, 1944). The yield of the SeMet enzyme
is 30 mg per litre of culture. Mass spectro-
metry (data not shown) con®rmed the
incorporation of selenium into the protein.
2.3. Crystallization of selenomethionyl
P. aeruginosa ADI
The puri®ed enzyme samples were
concentrated to about 10 mg mlÿ1 by ultra-
®ltration (YM30, Amicon) and the protein
concentration was estimated by UV
absorption based on a calculated absorption
molar coef®cient of 54 270 Mÿ1 cmÿ1 at
280 nm (Kalckar & Shafran, 1947).
Crystallization attempts were performed
by the sitting-drop vapour-diffusion method
using 24-well tissue-culture VDX plates
(Hampton Research) at 293 K. Initial sear-
ches for crystallization conditions were
performed using the standard sparse-matrix
crystal screens (Jancarik & Kim, 1991) from
Hampton Research (Crystal Screen I and
Crystal Screen II) and further re®ned.
Crystals of P. aeruginosa ADI emerged from
several conditions. These conditions were
re®ned and the best crystals were obtained
with 100 mM sodium cacodylate buffer pH
6.5, 55% MPD and 20 mM MgCl2. In each
trial, a sitting drop of 5 ml of protein solution
(10 mg mlÿ1 in 50 mM Tris±HCl buffer pH
7.4, 10% glycerol, 0.2 mM EDTA, 3 mM
-mercaptoethanol) mixed with 5 ml of well
solution (100 mM sodium cacodylate buffer
pH 6.5, 55% MPD) was equilibrated against
a reservoir containing 600 ml of well solu-
tion. Typical crystals grew as regular blocks
of dimensions 0.20  0.20  0.40 mm in
about 3 d (Fig. 2).
3. Data collection and analysis
Preliminary diffraction data were collected
on a MAR345 imaging-plate system from
MAR Research equipped with Osmic optics
and running on an FR591 rotating-anode
generator (Cu K).
The crystals display tetragonal symmetry
(P41212 or P43212), with unit-cell parameters
a = b = 106.0, c = 300.2 AÊ . The large c cell
parameter combined with the large mosa-
icity of the crystals caused the diffraction
spots to overlap when the detector was too
close to the crystal, limiting resolution.
Crystals were ¯ash-frozen and diffraction
data were collected on a MAR CCD
detector on beamline BM30 at ESRF
(Grenoble). Diffraction data were recorded
using the multiwavelength anomalous
diffraction (MAD) method in order to
obtain initial phase information for struc-
tural determination. Prior to collection of
the diffraction data, the X-ray ¯uorescence
spectrum of the ADI crystal was measured
in order to determine the absorption edge of
selenium. Three data sets for MAD calcu-
lation were collected with wavelengths of
0.9788 (peak), 0.9790 (in¯ection) and
0.9724 AÊ (remote) using a single crystal. The
distance between the crystal and the
detector was set to 200 mm as a compromise
between resolution and spot overlap.
Indeed, the combination of the long c cell
Figure 1
Coomassie-stained SDS±PAGE (8±25%) gel on a
puri®ed fraction of P. aeruginosa ADI showing a
single band at the expected MW of about 46 kDa.
Figure 2
Typical plate crystals of PAO selenomethionyl
arginine deiminase obtained by equilibration against
a reservoir containing 55% MPD, 100 mM cacodylate
pH 6.5, 20 mM MgCl2. The maximum size of the
crystals is about 0.400 mm.
Table 1
Data-collection statistics.
Values in parentheses are for the highest resolution shell.
In¯ection Peak Remote
High-resolution
pass
Wavelength (AÊ ) 0.97905 0.97888 0.97243 0.97888
Resolution (AÊ ) 99±3.24 (3.32±3.24) 99±3.24 (3.32±3.24) 99±3.22 (3.30±3.22) 99±2.70 (2.83±2.70)
No. measured re¯ections 277287 280949 285130 259812
No. unique re¯ections 59392 59374 61846 94298
Completeness (%) 99.2 (97.8) 99.4 (98.2) 99.2 (97.2) 91.1 (69.0)
Rmerge (%) 9.9 (29.4) 10.0 (35.5) 9.7 (28.1) 8.0 (31.3)
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parameter and high mosaicity limits the
distance between the crystal and the
detector and hence restricts the resolution of
the data set. Under these conditions, the
crystal diffracted to only about 3.20 AÊ . Data
were processed with the programs DENZO
and SCALEPACK (Otwinowski & Minor,
1997) and the results are summarized in
Table 1. The overall completeness at the
three wavelengths is about 99.2% in the
resolution range 99.0±3.24 AÊ , with overall
Rsym values below 10.0%.
No serious radiation damage to the crystal
was detected during the ®rst data collection
at the three different wavelengths and
therefore a higher resolution pass was
recorded on the same crystal by moving the
! angle of the detector to 10, leading to a
set with slightly higher resolution. For this
second data set, the statistics showed an
overall completeness of only 91.1% in the
resolution range 99.0±2.70 AÊ , with an overall
Rsym of 8.0% and an Rsym of 31.3% for the
last shell (2.83±2.70 AÊ ).
4. Structure analysis
Biochemical studies suggest that the active
arginine deiminase is a tetrameric protein
with a molecular weight of about 46 kDa per
monomer (Baur et al., 1989). Based on the
sequence of the enzyme, 11 (Se)Met resi-
dues are expected for each protein subunit.
According to the cell size and symmetry,
the solvent content is calculated to be
51.3%, assuming four molecules in the
asymmetric unit and a density of 1.30 g mlÿ1.
The Matthews coef®cient (Matthews, 1968)
is 2.622 AÊ 3 Daÿ1 based on a molecular
weight of 46 400 Da per subunit for ADI.
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